Name: “Advancing Translational Sciences Through Multi-Disease Platforms and Technologies”
Start: 2021-09-02T12:00:00-07:00
End: 2021-09-02T13:00:00-07:00

About this Event

Virtual Event

Add to calendar

Part of the USC/CHLA Cell Therapy Program Seminar Series

Speaker:

Marc Ferrer, Ph.D.
Director, 3-D Tissue Bioprinting Laboratory

Division of Preclinical Innovation
Early Translation Branch
National Center for Advancing Translational Sciences

Learn more about :

NCATS advances translational sciences through collaborative research.
NCATS builds translational platforms and technologies to address multiple diseases at a time.
NCATS uses engineered tissues as a technology platform for disease modeling and drug screening

https://usc.zoom.us/webinar/register/8516287837215/WN_wr_DaMgdTQODknw-hWhSYQ

This program is open to all eligible individuals. USC operates all of its programs and activities consistent with the university’s Notice of Non-Discrimination. Eligibility is not determined based on race, sex, ethnicity, sexual orientation or any other prohibited factor.

“Advancing Translational Sciences Through Multi-Disease Platforms and Technologies”

Event Details

See Who Is Interested